Lipid Nanoparticle Immunogenicity & Toxicity Summit

Paid

Enhance Your Prediction of PKPD, Accurate Dosing Regime & Immuno-Modulation of LNP for Long-Term Patient Safety & Potency Following the success of LNP-mRNA vaccines, we have seen an influx of novel types of lipids based nanocarriers over the last 12 months, progress has been made to minimize immuno-toxicity challenges – from maximizing therapeutic

06-08 December 2022

Healthcare

3rd Tumor Myeloid-Directed Therapies Summit

Paid

Welcome to the 3rd Tumor Myeloid-Directed Therapies Summit
The role of the myeloid compartment in tumor resistance is becoming clear. As the landscape of targets continues to grow, the potential to target and manipulate myeloid cells to relieve immunosuppression has received increasing focus, due to its ability to relieve immunosuppression in th

18-20 July 2023

Healthcare